Sanders W E, Hartwig E C, Schneider N J, Cacciatore R, Valdez H
Antimicrob Agents Chemother. 1977 Aug;12(2):295-7. doi: 10.1128/AAC.12.2.295.
Of 21 antimicrobial agents tested in vitro, amikacin was the most predictably active against clinical isolates belonging to the Mycobacterium fortuitum complex; however, only 50% of strains studied were susceptible to clinically attainable concentrations of the drug.
在体外测试的21种抗菌药物中,阿米卡星对偶然分枝杆菌复合体的临床分离株活性最具可预测性;然而,仅50%的研究菌株对该药物临床可达到的浓度敏感。